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Immunohistochemical Techniques and
Their Applications in the Histopathology
of the Respiratory System
by Ilona Linnoila*t and Peter Petruszt
Subsequent to the first report in the 1940s on incubation of tissue sections with fluorescein-conjugated
antibodies for localization of antigens, a great number of modifications were introduced to improve the
validity of immunohistochemistry which has become a growingly popular tool. The use of immuno-
enzymatic techniques eliminates the need for expensive fluorescence microscopy equipment, the lack of
permanency of preparations and the lack of electron density required in ultrastructural localization of
antigens. Regardless of the technique, it is also important to choose a correct fixation which allows the
proper preservation of antigens and morphology and the penetration of antibodies through the entire
thickness of the preparation. A variety of immunohistochemical techniques have been applied to study
several components of the lung, such as collagen, surface active material, lung specific antigens, and
enzymes and the detection of tumor markers, immunoglobulins and infectious agents in the respiratory
system which is reviewed. The large surface area and the multiplicity of cell types provided by the
respiratory tract epithelium of humans for exposure to microbial as well as toxic substances in the
environment make this organ system very vulnerable but a good early indicator of adverse health effects.
Immunohistochemistry provides valuable information complementary to the immunochemical and
biochemical characterization of this barrier.
Introduction
In recent years immunohistochemistry (IHC) has
become an increasingly popular and effective tool in
research and diagnostic laboratories. The manifest
success of this method is due to technological improve-
ments, increased availability of purified antigens,
antisera, and other reagents, and the accumulation of
practical experience in a variety of applications. IHC
combines the advantages of the high specificity and
affinity ofantibodies in recognizing tissue antigens with
the high topographical resolution of light and electron
microscopy. It can thus provide information which would
be difficult or impossible to obtain by other techniques
(1-6).
Applications of IHC have contributed significantly to
our knowledge about the distribution and pathological
reactions of several components of the lung such as
collagen, surface active material, lung-specific antigens,
and enzymes; the method has also been applied to the
detection of tumor markers, immunoglobulins, and
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infectious agents in the respiratory system. The first
part of this review will deal with general principles of
IHC techniques, while the second part will discuss
particularapplicationsrelevanttopulmonaryphysiology,
pathology and toxicology.
Immunohistochemical Techniques
Development of Immunohistochemical
Techniques
The origin of the IHC techniques goes back to the
early 1940s when Coons et al. (7) reported that
fluorescein-conjugated antibodies were useful in demon-
strating bacterial antigens in infected tissue. The sim-
ple principle of this "direct" technique is schematically
illustrated in Figure 1A. The method involved a single
incubationofthetissuepreparationswiththefluorescein-
conjugated antibodies directed againstthe antigen tobe
localized. Subsequently this original technique under-
went many modifications, all aimed at improving its
practicability and efficiency. The first major innovation
(8) eliminated the need for conjugating each individual
antiserum with the fluorescent dye by using uncon-
jugated antibodies in the first step, followed by a
secondary conjugated antibody directed against theLINNOILA AND PETRUSZ
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FIGURE 1. Immunohistochemical techniques: schematic representa-
tion of their development. (A) The direct technique with labeled
primary antibody (7). (B) The indirect, sandwich, or two-layer
technique (8,12) with labeled anti-IgG in the second layer. (C) The
three-layer immunoglobulin-enzyme bridge (11,21,22) with unla-
beled antibodies; anti-IgG in the second layer forms the bridge
between first- and third-layer antibodies; binding sites of the
third-layer antibody (usually anti-HRP) are free to bind marker
enzyme. (D) The PAP (23) method; preformed peroxidase-
antiperoxidase complexes (dashed circle) are used in the third
layer. (E) The double bridge (27); incubations with second- and
third-layer antibodies are repeated, in this order, followed by a
single incubation with HRP (F) The double PAP technique (28);
second- and third-layer components are applied repeatedly (more
than twice ifnecessary). For additional explanations, see the text.
immunoglobulins of the species from which the first or
primary antiserum was derived (two-layer, sandwich or
indirect technique) (Fig. 1B). For example, rabbit
antiserum to the antigen is followed by fluorescein-
conjugated sheep anti-rabbit gammaglobulin. Since the
latter antibodies recognize determinants common to all
rabbit IgG molecules (Fc region), a single conjugated
reagent can be used forthe localization ofany number of
tissue antigens as long as suitable rabbit primary
antiserum is available. In addition, since several mole-
cules ofthe labeled antibodies can bind to one molecule
of primary antibody (a feature not shown in Fig. 1),
substantial amplification of the staining is achieved.
This technique is still used today with good success in
many laboratories throughout the world. However,
difficulties in preparing effective conjugates, the need
for expensive fluorescence microscopy equipment, fre-
quent incidences ofdisturbingbackground fluorescence,
the lack of permanency of the resulting preparations,
and the lack of electron density ofthe fluorescent label
have all combined to stimulate the search for more
convenient and versatile labels. The first such "sub-
stitute" label was ferritin (9), which is still popular since
it permits high resolution at the electron microscope
level. Ferritin can be used as a label chemically conju-
gated to the primary or secondary antibodies instead of
fluorescein, as in Figure 1A or 1B. It can also be used as
part of a more efficient ferritin bridge (10), to be
discussed later. Several enzyme labels were suggested
andamongthese horseradishperoxidase (HRP) emerged
as the most popular (11,12). This enzyme, when used
with suitable substrates (13,14), produces colored reac-
tion products which are properly localized, stable, and
electron dense, permitting ordinary light microscopy as
well as electron microscopy. Other enzymes are also
being used with good results with the various methods
represented in Figure 1: acid phosphatase (15), alkaline
phosphatase (11), glucose oxidase (16,17), and smaller
hemelike molecules with peroxidase activity (18-20).
These labels eliminate most of the disadvantages of
immunofluorescence except the inconvenience and the
loss of potency due to chemical coupling of the label to
the antibodies. This last problem was solved in 1969
when Avrameas (11), Mason et al. (21), and Sternberger
and Cuculis (22) independently described the so-called
unlabeled antibody or bridge methods. In these tech-
niques, antibodies directed against HRP (and derived
from the same species as the primary antibody) are
used as a third layer. Thus, all chemical labeling is
eliminated, since HRP will bind to the third-layer
antibodies by immunological mechanisms as an antigen
(three-layer, bridge, or unlabeled antibody-enzyme
techniques) (Fig. 1C). The ferritin bridge introduced by
Willingham et al. (10) works on the same principle,
usingaffinity-purified antiferritin antibodies inthe third
layer. The bridge technique afforded further amplifica-
tion over the two-layer sandwich as well as the addi-
tional benefit ofavoiding chemical labeling ofantibodies
altogether. In a further improvement, Sternberger et
al. (23) demonstrated that HRP and its antibodies form
stable soluble complexes (Peroxidase-Anti-Peroxidase
or PAP complexes) and these can be applied as a single
reagent in the third layer (Fig. 1D). Effective measures
improving the binding ofthe primary antibody to tissue
antigenic sites (extended incubation times), preventing
nonspecific binding (blocking with normal sera, use of
high dilutions of primary antisera), and optimizing the
conditions for the enzyme-substrate reaction have re-
sulted in a degree ofefficiency never before possible in
IHC staining (24-26). Furthermore, it has been shown
(27,28) that additional amplification (and greater sen-
sitivity) can be achieved by extending the length ofthe
bridge through repeated incubations with the second-
and third-layer components (double bridge techniques,
Figs. 1E and 1F).
Protein A (29) may be used instead ofthe anti-IgG as
the second-layer component (30), either to bear a
suitable marker or to form a bridge with anti-HRP
antibodies. In recent years, colloidal gold particles have
been used as markers with good advantage (31-34).
Additional variants of the bridge principle rely on the
avidin-biotin system instead of immunological binding
(35,36). These methods are very promising and seem to
offer certain advantages over the "classical" bridge
procedures; however, it remains to be established
whether or not the use ofprotein A, avidin or biotin as
IHC reagents creates any unexpected problems with
regard to specificity.
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Preparation of Tissue
It has been shown, especially with the more efficient
enzyme labels and multilayer techniques, that many
endogenous and exogenoustissue antigens areremarka-
bly resistant to the effects of denaturing (alcohols,
acetone) and crosslinking (aldehyde) fixatives and rou-
tine paraffin embedding procedures. For lung tissue,
frozen sectioning after filing of the alveoli with opti-
mal cutting temperature (OTC) embedding compound
(Tissue-Tek II, Miles Laboratories, Elkhart, IN) to
ensure expanded state ofthe lungparenchyma, followed
by acetone fixation was found excellent for immuno-
fluorescent studies (37). Frozen sectioning and the
concomitant loss ofstructural integrity maybe replaced
by sectioningfixed tissue blocks in aspecial instrument,
the Vibratome (Oxford Instruments, Columbia, MD).
Sections ofup to 100 ,um thickness can beprepared and,
after permeabilization (see below), stained with any of
the available peroxidase techniques. After evaluation
with the light microscope, the stained sections or parts
of them can be embedded in plastic and further pro-
cessed for electron microscopy. Such 'pre-embedding"
staining is one of the most powerful approaches avail-
able today (38-42). More detailed guidelines for the
selection of fixation and embedding procedures are
given by Sternberger (5) and Pearse (4). Following the
suggestion ofthe latterauthor, itisrecommended that a
suitable series of methods be tested whenever a new
problem is being considered. This should include: rou-
tine formaldehyde fixation, paraffin embedding; routine
Bouin's fixation, paraffin embedding; cold ethanol or
acetone fixation, paraffin embedding; any of the above
fixatives, frozen or Vibratome sectioning; fresh frozen
sections, any suitable- fixative. Fixation must be fol-
lowedbythoroughwashinginphosphate-buffered saline
(PBS) to remove excess fixative and thus facilitate
optimal immunostaining.
Penetration of the antibodies through the entire
thickness ofthe section is essential forbest results. The
organic solvents used duringparaffin processing appear
to render such sections permeable; however, when fixed
frozen or Vibratome sections are used, treatment ofthe
sections with detergents (38,43,44) or ethanol (Petrusz,
unpublished) is essential before application of the pri-
mary antibody.
Unmasking of Antigens in Tissues
with Proteolytic Enzymes
The detection ofmanytissue antigens is facilitated by
treatment of the sections with proteolytic enzymes
prior to IHC staining. Such treatment results in both
intensification of specific staining and reduction of
nonspecific background. This is well documented for
immunoglobulins (45-48) and various infectious agents
(49-51), and promising results were observed with
neuropeptides (52) and pituitary hormones (Petrusz,
unpublished). Trypsin (49), pepsin (53), and pronase
(47) have all been recommended, and the required
conditions seem to vary with both the methods oftissue
processing and the enzyme used. As pointed out by
Curran and Gregory (46), pretreatment withproteolytic
enzymes permits the use ofmuch higherdilutions ofthe
primary antisera, thus reducingnonspecificbackground
and staining of unwanted antigens (see below).
Criteria of Validity
Performing IHC staining is relatively easy, but cor-
rect interpretation ofthe results presents some unusual
problems. Interpretation should be based on generally
accepted criteria of validity. Such a set of criteria,
including efficiency, accuracy, precision, sensitivity and
specificity, have been proposed by Petrusz et al. (54).
These criteria have been defined and procedures have
been outlined whereby IHC staining can be improved
and the results interpreted in terms of these criteria.
Among the proposed criteria of validity only two,
efficiency and specificity, will be discussed here, since
these are the most essential ones and have direct
bearing on the performance and interpretation of IHC
staining. For further details, the reader is referred to
other publications (2,4-6,54,55).
Efficiency
Efficiency in IHC staining is defined as the signal-to-
noise ratio in a stained preparation. Clearly, the im-
provements represented in Figure 1 fromA to F are all
aimed at maximizing the signal, i.e., the quantity or
intensity of label attached to a given antigenic site in
the tissue. Efficiency may also be improved by facilitat-
ing the binding of the primary antibody to the tissue
antigen (extended incubation time, low ionic strength
buffer, close to neutral pH detergents in buffer) and by
taking effective steps to reduce any possible back-
ground staining. The latter can be achieved by saturat-
ing nonspecific binding sites with proteins from normal
sera, by using purified antisera if necessary, and in
general by adjusting the conditions ofall incubations to
favor specific but to prevent nonspecific binding. Effici-
ency may be improved by treating sections with
proteolytic enzymes prior to immunostaining. Optimal
efficiency in a given system is best found by titration,
determining the dilution of the primary antiserum
which produces maximum specific staining without
nonspecific background. Naturally, aprerequisite ofthis
procedure is prior rigorous standardization of all other
steps involved in the particular technique used. Such
standardization and titration should precede all defini-
tive IHC work.
Specificity
Two fundamental sources ofnonspecifi city have been
defined in IHC staining: method nonspecificity and
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antibody nonspecificity (5,55). This approach to speci-
ficity is useful because it is generally valid for all IHC
techniques and it offers relatively simple practical
guidelines to solve or prevent actual problems of
nonspecificity.
Method nonspecificity essentially includes all staining
that commonly would be described as "artifact'" It may
arise from binding to the tissue of any other staining
component than the primary antibody (e.g., protein-
protein interactions) (56) or from generation of a false
signal through mechanisms unrelated to the IHC stain-
ing (e.g., endogenous peroxidase, tissue autofluores-
cence). The use of the highest possible dilution of the
primary antiserum and omission of individual steps
(reagents) from the staining sequence will be very
helpful in identifying and eliminating some of these
problems. As a perplexing example, mast cells have
been constantly reported (57-62) to bind antibodies in
their granules by immunofluorescence and immuno-
peroxidase techniques. Many naturally occurring sub-
stances (e.g., collagen, porphyrins, cartinoids) show
autofluorescence. In addition, exogenous substances
such as drugs (acridines, certain antibiotics, salicylic
acid derivatives) and other chemicals can be detected by
fluorescent microscopy and thus can be the sources of
false positive results in immunofluorescent studies (60).
Withimmunoperoxidasetechniques, endogenousperoxi-
dase activity may be particularly disturbing in lung
tissue where peroxidaselike enzymes are present in
macrophages (60,63), in erythrocytes and leukocytes
trapped in the rich vascular system (64), on surfaces of
alveolar cells (64), and in epithelial cells lining the
bronchial tree (64,65). Unless proven otherwise, it
should be assumed that such enzymatic activity sur-
vives the fixation and embedding procedures commonly
employed. Endogenous peroxidase can be (1) tolerated
ifit is known and not disturbing, (2) inactivated by any
of several available methods before immunostaining
(1,59,66-68), or (3) reacted with a substrate producing
different color than that used for the immunostaining
(69).
The ultimate question to be answered in every IHC
staining is the question of antibody specificity: how
confident can one be concerning the identity of the
tissue antigen localized. From this point of view, IHC
does not differfrom otherimmunochemical systems: the
specificity ofthe antibodies responsible for a given IHC
staining can only be defined by studying the interaction
ofthese antibodies with known antigens ofhigh purity.
However, IHC methodsperse are not based on competi-
tiveinteractions suchas, e.g., radioimmunoassay(RIA).
In RIA only those antibodies will be operative which
recognize (bind) the radioactive tracer; all other anti-
body populations present in the antiserum can be
excluded from consideration. In IHC, all antibody
populations which find a complementary antigenic site
in the tissue will bind and produce staining. Conse-
quently, inhibition ofthe IHC staining with known and
pure antigens (absorption) is the only direct method to
gain information on the specificity of the staining, i.e.,
onthe identity ofthe antigen localized. This information
is not absolute, since it evidently refers only to the
antigenic site and not to the entire molecule of the
antigen. When an antigenic site occurs as a partial
sequence in two or more larger molecules (a frequent
possibility), it is clearthat the absorption test alone will
not be sufficient for identification ofthe tissue antigens
stained. (It should be noted that this as well as most of
the previous arguments apply to both conventional and
monoclonal antibodies.) In such cases, one possible
recourse is to search for antisera which might recognize
a different portion ofthe antigen not shared with other
molecules. Otherwise IHC results must be supported
by physiological or biochemical data concerning the
identity of the antigen localized.
Absorption or "blocking" is usually done by combining
known amounts of the antigens with working dilutions
of the primary antiserum. If the antigen binds to the
sites that are critical for immunostaining, subsequent
staining will be blocked or inhibited. Since the tissue
antigen is in insoluble phase, it will be favored by the
antibodies versus the antigen added in soluble form;
therefore, it may be necessary actually to remove
antibodies from the solution, either by creating suitable
conditions for the formation ofan insoluble precipitate,
orbyusingantigencoupledtoinsoluble carrierparticles.
Similar liquid or solid phase systems may also be used
to assess cross-reactivities of antisera and to purify
antisera by removing unwanted antibody populations.
Further theoretical and practical questions concerning
specificity and other criteria of validity have been
discussed elsewhere (54,55).
Interpretation of Staining
The great popularity of IHC techniques leaves no
doubtabouttheirusefulness andpracticability However,
for correct interpretation of the results it is extremely
important to follow certain routine rules ofstandardiza-
tion and to perform all necessary controls. In our view,
method specificity in most cases should be practically
absolute, with only very few exceptions (e.g., peroxi-
daselike activity in blood cells when specific staining is
clearly separated from the vascular compartment). The
method, including the enzyme-substrate reaction,
should be standardized so that conditions are optimal
and do not vary from one staining to the next. This will
ensure reproducible results when identical materials
are used. Titration should establish the optimal dilution
of the primary antiserum and no staining should be
present at extremelyhigh dilutions (method specificity).
Antibody specificity should be evaluated by at least one
of the available absorption procedures and addition of
excess antigen should inhibit the staining. Moreover,
any additional other evidence (physiological, biochemi-
cal, pathological) should be sought and evaluated to
support the validity ofthe conclusions drawn from IHC
results.
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Immunohistochemistry of Specific
Components of the Lung
Collagen
In much of the early immunochemical work on
extracellular sites ofcollagen and reticulin, which is not
reviewed here, it was difficult to assess the role of
contaminating antigens, particularly serum proteins.
However, in 1969 Nagasawa and Shibata (70) found
immunofluorescence in human alveolar capillary base-
ment membrane with fluorescein-labeled antiserum to
human glomerulal basement membrane. Engel and
Catchpole in 1972(71)demonstratedimmunofluorescence
in alveolarwalls and inthe lamina propria ofthe airways
in the rat using a specific antiserum against rat tail
collagen. The antibody reacted with several forms of
isolated collagen but not with rat serum. Basement
membranes and reticular fibers of other organs were
also stained.
Subsequently, purified antibodies to distinct types of
interstitial collagens and procollagens (types I, II, and
III) were used for aqualitative survey on distribution of
various collagens in many IHC studies on healthy as
well as diseased tissues (72). Purified antibodies against
both human and mouse type IV collagen reacted in
indirect immunofluorescence tests with basement mem-
branes in various human and mouse tissues including
the lung (73). The findings indicated that various
basement membranes might contain related or identical
collagenous proteins with a high degree ofinterspecies
homology. All types ofcollagen (types I, II, III, IV and
AB2 or V) have been found in the lung (74). In an
immunofluorescence study of pulmonary fibrosis with
affinity-purified antibodies in 1980, Madri and Furth-
mayr (74) assessed the relative amounts of collagens in
different locations. TIype I collagen was markedly in-
creased in alveolar septae, type III was markedly
reduced and observed only perivascularly, type V was
considerably increased in the interstitium and located in
areas of smooth muscle cell proliferation. No change
was noted with type IV collagen. These IHC results
were consistent with the results obtained with various
othermethods such as dissection, isolation and composi-
tional analysis.
The previously cited IHC work on collagen ofthe lung
was performed on fresh frozen material with fluorescein
label. But there is cumulative evidence that at least
collagen type IV antigenicity is preserved through
conventionalformaldehyde-fixation andparaffin process-
ing (75,76). Ultrastructural localization of a soluble
collagen antigen (77) and type IV antigen (78) was
obtained in the trachea of chick embryos and endothe-
lial cells of gums, respectively, by a post-embedding
immunoperoxidase technique. At the time of preparing
this article immunoelectronmicroscopical studies on
collagen synthesis in the lung were not available. In the
future they may provide useful information on the
pathogenesis ofpulmonary fibrosis which composes 20%
of the noninfectious diseases of the lung, and is often
associated with drugs or toxic substances.
Surface-Active Material
Following the discovery in 1958 of the surface-active
lipoprotein layer, so-called surfactant, that forms the
interface between gas and liquid in the alveoli (79), the
demonstration ofthe material was dependent upon the
surface tension lowering effects oflungextracts until an
IHC study by Craig (80). In 1964 he obtained an
antiserum to washed foam from autopsied human lungs
that did not cross-react with human serum proteins and
was localized by fluorescence microscopy on the alveolar
walls ofhuman lungs. Since all commonly used fixatives
dissolved the antigen from specimens, he mainly used
unfixed cryostat sections for his study on the distribu-
tion of surface-active material in the lungs of infants
with and without respiratory distress. He described the
progression from intracellular to both intracellular and
alveolar, and then to solely alveolar localization, of the
specific antigenic protein during the gestation period.
In a number of immunochemical analyses, different
preparations ofsurface-active material were found also
to contain serum protein antigens (81). Ultrastructural
demonstration of plasma proteins, namely autologous
albumin and IgG in the alveolar lining material of the
normal rat lung was reported by Bignan et al. (82-84)
with an immunoperoxidase technique: fibrinogen was
not found undernormal conditions. Deposits ofC3, IgG,
fibrin and occasionally C4, factor B and IgM were
demonstrated by immunofluorescence also in hyalin
membranes ofinfantswhodiedwithgroup B streptococ-
cal sepsis or idiopathic respiratory distress syndrome
(85). Thus it was suggested that immunologic processes
might contribute to the pathogenesis of certain acute
lung injuries in infants.
In 1973, Klass (81) used absorbed rabbit antibody
against dog pulmonary surface-active material that did
not cross-react with dog serum. Specific staining in
cryostat sections ofdoglungwas observed in the alveoli
and also in the walls and mucosal surfaces of the large
airways but was lost from the alveolar surfaces after
fixation and processing of the tissue. An RIA of
pulmonary surface-active material in sheep lung was
developed in the same laboratory (86) and offered for
evaluation ofthe maturity ofthe lung. In 1977, Sueishi
et al. (87), using immunoelectron microscopy after
pre-embedding immunoperoxidase staining of glutaral-
dehyde fixed cryostat sections, were able to demon-
strate surface active material in the alveolar lining
layer, close to tubular myelin figures and in lamellar
bodies of Type II pneumocytes in rabbit lung. No
reaction product was detected inside the epithelial cells
ofairways. Theirantibody was raised in ducks against a
protein extracted from saline endobronchial washings
from normal rabbit lungs (88), and absorbed with rabbit
serum (89). Although ultrastructural morphology was
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compromised, immunohistochemically the results were
convincing. In 1981, Williams and Benson (90) improved
ultrastructural localization of the major surfactant
protein with an antibody to purified material from rat
lung. In adult rat lung, the antibody labeled the rough
endoplasmic reticulum and Golgi apparatus of Type II
cells only, suggesting that these cells synthesize the
protein.
Katyal and Singh (91) studied surfactant apoprotein
first in the lungs from adult, newborn, and fetal rats by
the use of IHC. With antiserum specific for primate
surfactant, they demonstrated in 1980 that the extent
and intensity of staining for apoprotein was markedly
increased in reactive Iype II pneumocytes in nonmalig-
nant pulmonary disorders when standard formalin-fixed
paraffin sections were used (92). The same antisera
were usefulin IHC diagnosis ofsome bronchioloalveolar
carcinomas which consisted of Type II pneumocytes
(93). According to Bhattacharyaa et al. (94-96), a
specificglycoprotein ofmolecularweight36,000 appears
to be a component both in lung lavage and lamellar
bodies ofvarious normal animals as well as in alveoli of
patients with alveolar proteinosis (Fig. 2).
Studies with "Lung-Specific" Antibodies
Preparing an organ-specific antibody for the lung to
be used as atool in IHC studies on fetal development or
tumor formation may seem attractive. The fact that the
lung can be composed of as many as 40 different cell
types presents an inherentproblem. Ten Have-Opbroek
(97-99) prepared an antiserum specifically recognizing
the antigenic determinants of adult mouse lung tissue.
With IHC, the antigen appeared to be localized in 1rype
II cells. Akeson (100) demonstrated the presence of
lung tissue-specific (NL-1) antigen(s) in normal lung
tissue with IHC using a selected antiserum against a
lung tumor cell line.
Immunohistochemistry of Enzymes
in the Lung
Lysozyme
IHC investigations (101) have demonstrated lyso-
zyme in a number of different cell types, including
serous cells of bronchial glands (102), pointing to the
role of the enzyme as an antibacterial agent (103). In
respiratory tissue, lysozyme was localized with the
immunoperoxidase technique on formalin-fixed paraffin
sections (92, 104) in alveolar macrophages, Type II
pneumocytes, ciliary layer of the trachea and in secre-
tory cells in laryngotracheal glands in various rodents
and man. Specific staining was obtained with rabbit
anti-rat lysozyme or anti-human urinary lysozyme anti-
bodies but not with antibodies against egg white
lysozyme. Interestingly, the respiratory system of the
hamster, which is a useful experimental animal due to
itsrelatively lowpulmonary infectionrate (105), seemed
to be devoid of the lysozyme based on immunohisto-
chemical as well as biological activity studies (101). As
an interpretative caution,- Spicer et al. (101) tested
different fixatives and the specificity of the IHC stain-
ing in lung. In their thoroughly controlled system,
laryngotracheal serous cells still possessed an unex-
plained, selective property of (nonimmune) binding of
immunoglobulin. Such binding was also noted in mast
cells (61). However, Bowes et al. (106) reported specific
ultrastructural localization of lysozyme in serous cell
FIGURE 2. Localization ofa unique glycoprotein in the alveolar Iyrpe II cells ofthe rat lung (immunoperoxidase-bridge method) (26). Arrows
point to darkprecipitate in the alveolar walls associated with a specific antibody (a gift from Dr. S. N. Bhattacharyya) to the 36,000 molecular
weight glycoprotein which was purified from lamellar bodies (94-96). A formalin-fixed 6 ,um thick paraffin section counterstained with
toluidine blue x1300.
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granules in human bronchial glands. In comparative
studies of lysozyme between conventionally reared and
germ-free rats (107), IHC was of limited value, but
proved to be very useful in an ontogenic study of the
enzyme (108,109).
Pulmonary Monooxygenase Enzymes
The cytochrome P-450-dependent monooxygenase
system, which metabolizes endogenous as well as for-
eign compounds, is also present in the lung (110),
although at a lower concentration than in the liver.
Recent IHC localization of cytochrome P-450 isoen-
zymes and NADPH-cytochrome P-450 reductase in
specific cell types ofthe lung such as in Clara cells and
Tlype II pneumocytes probably reflects the fact that
these enzymes are present in cells in high enough
concentrations to be involved in organ specific carcino-
genesis or toxicity (111-114). The antigenicity of cyto-
chrome P-450 (Fig. 3) is retained after paraffin embed-
ding of paraformaldehyde-fixed tissues (113,114). IHC
provided valuable information complementary to the
immunochemical and biochemical characterization of
pulmonary monooxygenase system (115). With regard
to sensitivity, IHC techniques are likely to be superior
to conventional histochemistry, allowing better cellular
and subcellular resolution. However, the method re-
quires at least partial purification and characterization
ofthe enzyme ofinterest, which is not always feasible.
Also, immunoreactivity does not necessarily reflect the
presence of biologically active enzyme.
Angiotensin-Converting Enzyme
in Pulmonary Endothelial Cells
Angiotensin-convertingenzymeisamammalianpepti-
dase which metabolizes circulating bradykinin and
catalyzes the change ofangiotensin I to angiotensin II,
the vasoactive agent of the renin-angiotensin system.
Bradykinin and angiotensin I are metabolized during
theirpassage through the vasculature ofthe lung. Ryan
et al. (116) demonstrated with IHC that the converting
enzyme was actually localized along the luminal surface
of pulmonary endothelial cells. For pre-embedding
ultrastructural localization the authors used the anti-
convertingenzymeantibodycoupledtomicroperoxidase
on glutaraldehyde or, preferably, paraformaldehyde-
picric acid-fixed tissue (117). The strategic location
suggested that the enzyme might help regulate the
entry ofbradykinin and angiotensin II intothe systemic
arterial circulation. Furthermore, this regulation could
easily suffer from diseases that specifically damage the
pulmonary endothelium as demonstrated with IHC
techniques in Rocky Mountain spotted fever (118).
The converting enzyme, localized by immunofluores-
cence, appeared as a good marker for studying the
development of the pulmonary vascular bed in rabbits
(119) or for identifying of pulmonary arterial endothe-
lial cells from calves in vitro (60). Besides the convert-
ing enzyme, other antigens (120-122) have also been
localized in the endothelial cells by IHC thus providing
possible tools for further studies on these metabolically
important cells of the lung.
Other Enzymes
Endogenous peroxidases have been histochemically
demonstrated in various alveolar and bronchiolar cells,
including macrophages (123,124), and we have already
discussed the implications in regard to nonspecific
staining with immunoperoxidase techniques. Further-
more, endogenous peroxidases may hamper the use of
IHC todemonstrateexogenoushorseradishperoxidase,
FIGURE 3. Localization ofcytochrome P-450I in the apices ofnonciliated epithelial cells ofa terminal rabbit bronchiole (PAP-technique) (5): (A)
control, treated with normal serum; (B) arrows point to the reaction product associated with the specific antiserum which was diluted
1000-fold and located in Clara cells (113-115); L, lumen of a bronchiole. IAS, interalveolar septa. These photomicrographs courtesy of
Dr. C. J. Serabjit-Singh. x620.
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FIGURE 4. Photomicrographs ofneuron-specific enolase (NSE) (127- 129) in the lung (immunoperoxidase-bridge method, (26). (A) Localization
of NSE in neuroepithelial bodies (NEB) and in solitary cells (arrowheads) ofthe bronchial epithelium ofthe guinea pig. Note that bronchial
lumen (L) is filled with erythrocytes which contain endogenous peroxidase, x440. (B) A thick bundle of NSE-containing nerve filaments
(arrows) under a bronchial smooth muscle (sm) of the hamster; L, lumen of a bronchus x470. The antibody to NSE was a gift from
Dr. P Marangos.
which has been used as a marker for capillary (125) or
epithelial (126) permeability.
A glycolytic neuron-specific enolase isoenzyme, which
was originally extracted from bovine brain (127), was
recently demonstrated in neuroendocrinelike cells of
fetal lung using IHC (128). Neuron-specific enolase has
also been found in other endocrine (APUD or "amine
precursor uptake and decarboxylation") cells of the
central and peripheral divisions ofthe diffuse neuroen-
docrine system (129). This isoenzyme can provide the
capability of using the same IHC marker to delineate
various autonomic (e.g., adrenergic, cholinergic and
peptiderdic) nerves in the lung as well as different
pulmonary neuroendocrine cells, which with IHC have
been shown to contain for instance calcitonin (130), and
bombesin (131,132) (Fig. 4). In addition to enzymes,
protease inhibitors have been localized by IHC in the
respiratory system (133,134).
Markers of Lung Tumors
When the concept of IHC tumor markers was
generated, it was hoped that a marker would be
identified for each histologic type. Unfortunately, that
goal has not been realized (135,136). Carcinoembryonic
antigen (137), which was first discovered in extracts of
colonic tumor (138), was found in 20 to 30% ofbronchial
squamous cell carcinoma or lung adenocarcinomas by
IHC (139,140). The IHC localization of intracellular
keratin appeared helpful in establishing the epithelial
nature of poorly differentiated neoplasms, but in a
preliminary survey, primary lung tumors could not be
classified by keratin content (141).
Human chorionic gonadotropin and immunoreactive
growth hormone were localized in bronchogenic carcino-
mas with immunofluorescence (142,143). These hor-
mones have been associated mainly with large cell
carcinomas and adenocarcinomas of the lung (144). In
an IHC study of 29 oat cell carcinomas of the lung,
Deftos (145) demonstrated the presence of calcitonin,
1-endorphin or ACTH in all but three tumors. The
IHC localization ofhistaminase (146) as well as selected
polypeptide hormones, such as bombesin (147), in small
cell carcinoma of the lung revealed that within each
tumor different cells contained different amounts ofthe
compound.
Bell used IHC to demonstrate an antigen highly
associated with oat cell carcinoma and undetectable in
normal adult tissue (148). The antigen was also charac-
teristic of certain normal neural crest-derived cells in
the peripheral nervous system (149). The IHC localiza-
tion of the antigen was further correlated with the
presence of cytoplasmic neurosecretory granules (150).
In addition to this, neuron-specific enolase appeared as
agood markerfor oat cell carcinomas ofthe lung as well
as for other neuroendocrine tumors (151). These mark-
ers allow advance morphological investigations on small
cell carcinomas and other lung tumors that have re-
cently demonstrated to be quite heterogeneous with
regard to cellular composition (152,153). So far the
results are in concert with the suggestions ofBensch et
al. (154-156) and Hattori et al. (157-159), that small
cell carcinoma and carcinoid tumor of the lung may
originate from the pulmonary neuroendocrinelike cell
(Kultschitzky-cell).
In summary, IHC techniques have been useful and
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are well established in the field of tumor markers
(160-164), although thesearchforbettermarkersis still
warranted. Moreover, the IHC results of Katoh et al.
(165) demonstrated that blood group antigens were
good markers ofnormal human bronchial epithelial cells
and that the loss of blood group antigens might be
indicative of carcinogen-induced transformation of hu-
man bronchial epithelial cells.
Localization and Roles of
Immunoglobulins in the Lung
Immunoglobulins in the Lung
Part of the defense system of the lung against
micro-organisms is attributed to immunoglobulins. In
IHC studies, plasma cells and other immunoglobulin-
containing cells were found mostly in the submucosal
glandsbutwere also presentinthe laminapropria ofthe
human tracheal and bronchial epithelium. The greatest
number appeared in the main bronchi. The cells were
occasionally present around small bronchi and bronchi-
oles and were virtually absent from alveolarwalls (166).
Cells containing IgA were much more numerous than
those containing IgG, IgM, or IgE. The study was
performed with direct immunofluorescence on unfixed
cryostat sections which can be unsatisfactory in resolu-
tion of anatomical details. IgA was demonstrated in
epithelial cells of intramural glands of the human
tracheobronchial tree and at the luminal margin of
associated ducts near their origin (167,168). Mogi (167)
improved the localization by using alcohol-fixed paraffin
sections according to the method of Hamashima and
Kyogoku (169). Since secretory IgA differs in chemical
and immunological properties from serum IgA, Mogi
emphasized that individual antisera specific for the
secretory component and/or secretory IgA should be
used. A careful summary of IHC studies on various
aspects of glandular immunoglobulin transport in man
was presented by Brantzaeg (170). There was astriking
preponderance ofIgA-producing immunocytes adjacent
to glands ofthe respiratory tract, and serous glandular
cells selectively transported dimeric IgA. The epithelial
occurrence of IgG, most of which was serum derived,
was less conspicuous and restricted to the interstices.
The same epithelial cells were demonstrated to produce
a glycoprotein, the secretory component, which was
characteristically associated with IgA in apical parts of
the cells. Pentameric IgM was handled by the glands in
a way similar to dimeric IgA, but local synthesis ofIgM
was normally negligible in the respiratory tract. For
satisfactory morphology the author used a modified
Sainte-Marie (171) method with direct fluorescence.
Requirements and comments for reliable immunohisto-
chemistry ofimmunoglobulin-containing cells were also
given (170). Itisimportanttorealize thatepithelialcells
and eosinophilic granulocytes are most prone to become
nonspecifically stained in glandular sites (172,173) as we
pointed out previously.
Rudzik et al. (174) performed an interesting experi-
ment where bronchial and intestinal lamina propria of
rabbits was repopulated with IgA-containing cells after
transfer of homologous bronchial and Peyer's patch
lymphocytes. Directfluorescence onformalin-fixed cryo-
stat sections was used as described by Bienenstock et
al. (175). The immunoperoxidase technique on alcohol-
fixed paraffin sections was applied in studies of the
respiratory tract immune system in the pig (176,177)
and in sheep (178,179). In sheep, IgM was the main
immunoglobulin seen by immunofluorescence and per-
oxidase techniques in the nasal and bronchial glands
before suckling; after suckling also IgG was found at all
levels ofrespiratory tract. In adult sheep, IgA became
the major locally appearing immunoglobulin of the
respiratory system. Alley et al. (178) suggested that
immatureepithelialcellssuchasthosefoundinprolifera-
tive areas of diseased airways would be actively en-
gaged in immunoglobulin transport.
Response to Infections
Immunoglobulin production in lungs of hamsters
experimentally infected with Mycoplasmapneumoniae
was studied by Fernald et al. (180) with indirect
immunofluorescence in acetone-fixed cryostat sections.
In control lungs only IgA-containing plasmacytes were
found, but duringthe infection varyingnumbers ofcells
which also contained other immunoglobulins, infiltrated
theperibronchialspaces. Non-immunoglobulin-stainable
lymphocytes increased in number, too. However, it is
important to recognize clinically silent infections such
as caused by Mycoplasma pulmonis in rats, since they
may significantly change the results of IHC studies on
respiratory system immunity in laboratory animals
(181).
Immunological Reactions
With direct immunofluorescence on unfixed cryostat
sections obtained from asthmatic patients through au-
topsy or surgery Gerber et al. (182) demonstrated that
IgE was present in the bronchial epithelium and along
the basement membrane. IgE was observed in the
bronchial glands of all patients with asthma and to a
lesser degree of many patients with chronic bronchitis
or normal bronchi. IgE was not detected in mast cells.
The presence anddistribution ofotherimmunoglobulins
did not differ from that in normal bronchi. In patients
with lung cancer Zeromski et al. (183) found large
amounts of immunoglobulins in plasma cells with a
predominance of the IgA and IgG classes.
l'ype II immune reactions have been thought to be
involved in several so-called diffuse lung diseases,
where the presence of immune complexes was verified
byIHC. Inprocainamide-inducedsystemiclupuserythe-
matosus specific nuclear fluorescence with deposition of
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either IgG or IgM and also C3 was found in pleura by
direct immunofluorescence (184). Churg et al. (185),
using formaldehyde-fixed paraffin sections, found IgG
in alveolar walls and vessels of a patient with systemic
lupus erythematosus. This was in agreement with
studies of Inoue et al. (186) who were able to demon-
strate granular deposits of IgG, complement (C3) and
DNA in the alveolar walls and in the alveolar capillary
walls in systemic lupus erythematosus pneumonitis. In
rheumatoid lung both IgM and IgM-rheumatoid factor
complexes as well as IgG were localized in alveolar
walls, vessels and adjacent to rheumatoid nodules
(187,188). In IHC studies on Goodpasture's syndrome,
which is characterized by development of antibodies to
alveolar and glomerular basement membrane antigens,
IgG and complement (C3) werelocalized both in alveolar
walls in the lung and in glomerular basement mem-
branes ofthe kidney (189-191). An experimental model
sharing these features and thus resembling Good-
pasture's syndrome was developed by injecting rabbit
anti-rat lung serum into normal rats (192). Based on
immunofluorescence, Levy et al. (193) reported an
example of autoimmune disease characterized by the
presence ofantitubularandantialveolarbasementmem-
brane antibodies associated with immune-complex
glomerulonephritis. In this study both human and rat
lungs were used in order to demonstrate indirect
immunofluorescence with the patient's serum.
Farmer's lung or allergic alveolitis' also belongs to
diffuse lung diseases which involve typie II and possibly
Arthus-type reactions. The main source of sensitizing
agents for this disease are Miropolyspora faeni and
Thermoactinomyces vulgaris, andthe IHC studieswith
patients' antisera were able toinclude the localization of
the causative agents (194). Although the most consis-
tent finding was a diffuse interstitial pneumonitis, the
walls ofthe bronchioles appeared rich in antigen when
the immunofluorescence technique on acetone-fixed
cryostat sections was used (195). The lungs showed
great numbers of fluorescing histiocytelike cells with
anti-C3 complement, suggesting the antecedent pres-
ence of antigen-antibody complexes. In an immuno-
fluorescent study on bovine hypersensitivity pneumo-
nitis, also caused by M.faeni, Wilkie et al. (196) found
that pretreatment of frozen sections with pH 2.8
glycine-HCI buffer was a necessary prerequisite for
specific staining for the antigen. The authors felt that
the buffer'unmasked" the antigen byeffectively eluting
antibodies bound to the antigen in vivo. Thus, routine
immunofluorescent staining of M. faeni antigen in
tissues ofindividuals with specific serumantibody titers
maybeinhibited bypriorcombinationwiththeantibody.
Antigens ofM. faeni were located in apparent associa-
tion with alveolar macrophages. In order to elucidate
the pathogenesis of farmer's lung, a number of animal
models were recently developed (197). Schallibaum et
al. (197) exposed rabbits intratracheally to enzyme I,
which is a highly immunogenic esterase isolated from
M. faeni. After repeated exposures, intracellular
antigen, immunoglobulin and complement could be
demonstrated in histiocytes by direct immunofluores-
cence on alcohol-fixed cryostat sections. The authors
suggested that direct enzyme action might contribute
to the farmer's lung type pneumonia in eliciting
tissue damage.
Diagnosis of Diffuse Interstitial
Lung Disease
So far immunofluorescence has found little applica-
tionindiagnostichistopathologyoflungtissue(198-200)
though it has been very valuable in renal disease.
Hogan et al. (201) studied small needle biopsy speci-
mens from 30 subjects with signs of diffuse interstitial
lung disease; immunofluorescence examination of biop-
sies from six cases yielded positive results. The authors
evaluated their study critically and in their summary
three points received general attention: (1) Eosinophils
and macrophages frequently demonstrated nonspecific
staining (45). To avoid such pitfalls, it was necessary to
identify positively any particular fluorescing cell by
staining the same section with hematoxylin and eosin
after immunofluorescence was completed. (2) An alter-
native to ascertain that the antibody deposits were
specific would be to demonstrate deposits of comple-
ment or antigen in relation to antibody. However, such
anapproach would be applicable onlyto a smallgroup of
uncommon pulmonary diseases (other than infections)
with known causative agents. (3) The small proportion
ofpositiveresults obtainedintheirstudymightindicate
that immunologic processes were involved at only one
stage in the progression of disease or of response to a
wide range of injuries that often have no humoral
immune background. Thus Hogan et al (201) concluded
that the artifacts encountered in lung IHC render it
difficult to obtain consistent results. Furthermore, the
way in which the specimens are obtained may contrib-
ute to the difficulty. A needle biopsy, as in the study by
Hogan et al. (201) may not provide enough proper
material of the affected area. On the other hand, in
autopsy material the amount of autofluorescence is
often increased. Fortunately, in most of the cases,
satisfactory material can be obtained through open
lung biopsy.
Based on direct immunofluorescence on fixed and
unfixed cryostat sections ofidiopathic interstitial pneu-
monias, Schwarz et al. (202) suggested that immune
complex deposition might play a role in pathogenesis
and that once mural fibrosis supervened, these com-
plexes (IgG and C3) were no longer demonstrable.
Physiologic abnormalities appeared to correlate with
the presence of fibrosis, which leads one to emphasize
the results ofthe previously mentioned IHC studies on
collagen (74). In this regard it was not surprising that
Warvik et al. (203) demonstrated evidence of antibody
and complementdepositsinalveolarcapillariesinonly6
instances out of 33 cases of fibrosing alveolitis with a
similar immunofluorescence technique. In 17 cases
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there was evidence of antibody in plasma cells or
germinal follicles.
Application ofIHCindiffuse lungdiseasesischalleng-
ing and important since diffuse lung diseases form a
large group in pulmonary pathology and are on many
occasions associated with previous exposure to toxic
agents (dusts, asbestos) or drugs.
Immunohistochemical Approach
to Infections of the Lung
Microorganisms Pathogenic to Man
Presently IHC applications in diagnostic pathology of
infections ofthe human lung are scanty despite the vast
literature on the IHC of various microorganisms. In
selected cases where other methods either failed or
were not practical, IHC techniques were used. A good
example is Legionnaires' disease pneumonia (204), in
which final diagnosis requires identification of the
organism in the tissue, sera or both. The causative
organism has been positively identified by immuno-
fluorescence in tissue sections from biopsies or autop-
sies and in secretions from the lung (205-207). As an
alternative to fresh or fresh-frozen material, formalin-
fixed paraffin sections can be used (205,208). Recently
Suffin et al. (208) identified Legionella pneumophila in
tissue sections by a new immunoenzymatic (glucose-
oxidase) procedure (17), that can be adapted to routine
diagnostic practice.
Rickettsia rickettsii is typically difficult to demon-
strate with histochemical stains (209,210) in tissue
sections because ofits small size, poor staining contrast
between the organisms and tissues, and the affinity of
the stains for normal tissue structures such as mast cell
granules which, because of their size and morphology,
can be mistaken for rickettsiae. Using direct or indirect
immunofluorescence, Hall and Bagley (211) succeeded
in identifying R. rickettsii in formalin-fixed paraffin
sections after trypsin digestion. The morphology in
these sections was far better than in frozen sections.
Distribution of rickettsiae and the vasculitis of the
pulmonary microcirculation coincided according to the
immunofluorescence study ofWalker et al. (118). These
authors speculated that the striking invasion of the
pulmonary vascular endothelium affects important
nonrespiratory (e.g., metabolic) functions of the lung,
contributing to the pathophysiology of Rocky Mountain
spotted fever. The organisms were never observed
within the alveolar lining cells or bronchial epithelium,
and thus person to person aerosol transmission of the
disease appeared unlikely.
If microorganisms cannot be cultured, IHC tech-
niques provide a valuable tool for pathologists, as
demonstrated by immunofluorescent identification of
Pneumocystis carinii on ethanol-fixed cryostat sections
ofthe human lung (212). Bacteriologic culture of speci-
mens taken at autopsy usually gives negative results,
but this may be due to the organisms being nonviable,
instead of not being present. Danielson et al. (213)
performeddirectimmunofluorescence studiesonHaemo-
philus influenzae and Neisseria meningitidis in post-
mortem formalin-fixed, paraffin-embedded tissues in-
cluding the lung. The identification of the bacteria was
facilitated by counterstaining with lissamine rhodamine
B (RB-200)-labeled antistaphylococcal globulins to coun-
teract nonspecific staining and tissue autofluorescence.
This may be ofimportance in demonstrating the organ-
isms in the lungwhich is often invaded also by staphylo-
cocci via the respiratory tract after death. Immuno-
fluorescence studies on H. influenzae in the respiratory
tract by means of a direct method on acetone-fixed
cryostate sections failed to demonstrate any correlation
between the presence of these bacteria and the atopic
state (214). In addition to this, there are a few scattered
reports ofimmunofluorescence techniques inidentifying
viruses or mycoplasma in the human lung (215,216).
The use of immunofluorescence is deemed necessary
when it is difficult to identify various pathogenic fungi
by conventional histopathologic methods. IHC tech-
niques add an attractive dimension of serologic speci-
ficity. Kaplan and Kraft (50) demonstrated how five
different fungi could be identified by the direct fluo-
rescent antibody method in trypsin digested, formalin-
fixed paraffin sections as well as in sections that had
been previously stained by the hematoxylin and eosin,
the Brown and Brenn or the Giemsa procedures. The
beneficial effect of trypsin treatment was also demon-
strated afterthemountingoforganisms oneggalbumin-
coated slides in comparison with the results on clear
slides. In tissue sections Kaplan and Kraft (50) recom-
mended 1% trypsin for 1 hr at 37°C as a most favorable
digestion method.
Experimental Infections in Animals
In experimental work, IHC techniques have been
often used to localize various infectious agents in the
airways and lung in order to investigate in detail the
routes of spread of specific micro-organisms. This has
been correlated with conventional histopathological
findings. In immunofluorescence studies on the patho-
genesis of infection with influenza A virus in mice
following exposure to aerosolized virus, Yielma et al.
(217) came to the conclusion, in agreement with
Lemercier et al. (218), that viral replication happened
earlier in the bronchi than alveoli. This appeared to be
in disagreement with the findings of Denk and Kovac
(219,220) who claimed that after intranasal inoculation
the replication started closer to alveolar sacs and later
spread to the bronchi. Acetone fixed cryostat sections
(217), ethanol-fixed paraffin sections (218) and unfixed
cryostat sections (219,220) were used. Tada and Ishida
(221) inoculated mice intraperitoneally with the PR8
strain of influenza virus and localized the virus with a
different immunofluorescence technique (222). In brief,
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FIGURE 5. Localization ofMycoplasma pneumoniae in human fetal trachea infected in organ culture (indirect immunofluorescent technique).
Specific fluorescence 48 hr postinfection is limited to ciliated epithelium (ce); (Bm) basement membrane. Reproduced with permission from
Collier and Clyde (236).
their method required antivirus antibody to be applied
with fresh non-immune serum (containing complement)
on acetone-fixed cryostat sections, and subsequent
incubation with a fluorescent antibody against comple-
ment. Initial spread ofvirus, which was first located in
reticular cells in the lung, was found to differ from that
afterintranasalinoculationofinfluenza virus (223-226).
The course of herpesvirus infection was studied in
rabbits (227) and in infant mice (228) by direct im-
munofluorescence on acetone-fixed sections. The in-
fluence of the route of administration of Newcastle
disease virus on host response in chickens was studied
byBeardandEasterday(229)withimmunofluorescence.
In domestic animals fluorescent antibody studies on
parainfluenza 3 virus infections in lambs (230) and in
enzootic pneumonia ofpigs (231) have been useful. Hill
(32) used peroxidase technique on ethanol-fixed paraffin
sections to demonstrate mycoplasmas in animal tissues.
Single organisms could be demonstrated and there was
no nonspecific staining in the lung.
In an effort to further examine host response to
infection, immunofluorescence was used to demonstrate
the Newcastle disease virus in the brain and trachea, as
well as globulins and specific antibody against the virus
in mononuclear cells, mucous glands and mucus in
tracheal mucosa of chickens which had been serially
sacrificed during 1 to 120 days after infection (232). A
similar study on chronic pneumonia in swine with
experimentally induced African swine fever was per-
formed with antisera against viral antigen, porcine
immunoglobulin, complement and fibrinogen on serial
unfixed frozen sections (233). The same approach was
also applied to human autopsy material (142). Localiza-
tion ofimmunoglobulins in the lung has been discussed
in the preceding section of our review.
In Vitro Models for Environmental
Research
The large surface area provided by the respiratory
tract epithelium ofhumans for exposure to microbial as
well as toxic substances in the environment makes this
organ system very vulnerable but agood earlyindicator
of adverse health effects. However, the complexity of
pulmonary defense mechanisms complicates definition
of the interactive effects of pollutants and infectious
agents. As a model, tracheal organ culture obtained
from human fetuses as well as animals was utilized to
maintain organized differential respiratory epithelium
in vitro (234). In this system Collier (234) used immuno-
histochemistry as a major tool for investigating the
epithelial injury by Mycoplasma pneumoniae (Fig. 5),
respiratory syncytial virus or parainfluenza virus type
3. A similar system was used in studies of murine
cytomegalovirus infection (235). These experiments
demonstrated that individual infectious agents can
invade the organized epithelium in different ways. The
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information was useful in defining the susceptible cell
type for different pathogens, and can be further applied
to explore the injury produced or modified by different
pollutants and toxic agents.
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